MSB 3.33% $1.40 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-705

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15 Posts.
    lightbulb Created with Sketch. 9
    Getting very sick of those claiming the n=12 figure determines the result is not sigificant.
    "Significance" is a formal criteria decided by the numbers. Lowering the sample size has the effect of reducing likelhood of significance but doesn't exclude it.

    A simple Z-test using a base population with proportion 0.12 success against a sample size of 12 with proportion 0.83
    The base population was guessed(!) at 500 (probably WAY under the actual pop size).
    The result is not very sensitive to this number as base size >> sample size.

    RESULT: Z = -7.0764. The value of p is < .00001. The result is SIGNIFICANT at p < .01.

    The only two reasons POSSIBLE for this to be wrong are:
    1) the sample was not representative of the background population
    2) The result was confounded by the use of other experimental agents

    From SI's comments & that a legally binding ANN has been produced, I see no sensible reason to believe either of these reasons have arisen.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.